Presentation is loading. Please wait.

Presentation is loading. Please wait.

 SC Guidelines for Diabetes Care 2011. Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting.

Published byBarnaby Banks Modified over 8 years ago

Similar presentations

Presentation on theme: " SC Guidelines for Diabetes Care 2011. Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting."— Presentation transcript:

1  SC Guidelines for Diabetes Care 2011

2 Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting Plasma Glucose (FPG), or 2-h 75-g Oral Glucose ToleranceTest (OGTT) are appropriate. An A1C level of 5.7% to 6.4% indicates increased risk for diabetes. The presence of diabetes is indicated by:  A1C level of 6.5 % or higher;  FPG level of > 126 mg/dl;  OGTT level > 200 mg/dl. Reference: American Diabetes Association. Standards of Medical Care in Diabetes- 2011. Diabetes Care. Volume 34, Supplement 1. January 2011 http://care.diabetesjournals.org/content/34/Supplement_1/S11.full

3  SC Guidelines for Care of Persons with Diabetes 2011

4 South Carolina Guidelines for Diabetes Care 2011

5

6 Level of evidence for most significant recommendations: A = Randomized Clinical Trial B = Controlled trials, no randomization C = Observational studies D = Opinion of expert panel E = Expert or clinical opinion

7 Approved by Diabetes Initiative of South Carolina September 2, 2011

Download ppt " SC Guidelines for Diabetes Care 2011. Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting."

Similar presentations

ADA Criteria for the diagnosis of diabetes Table 3—Criteria for the diagnosis of diabetes 1. A1C ≥ 6.5%. The test should be performed in a laboratory.

ADA Criteria for the diagnosis of diabetes Table 3—Criteria for the diagnosis of diabetes 1. A1C ≥ 6.5%. The test should be performed in a laboratory.
Diagnosis of Type 2 Diabetes 1. Glucose Testing and Interpretation: AACE Diagnostic Criteria TestResultDiagnosis FPG, mg/dL (measured after 8-hour fast)

Diagnosis of Type 2 Diabetes 1. Glucose Testing and Interpretation: AACE Diagnostic Criteria TestResultDiagnosis FPG, mg/dL (measured after 8-hour fast)
Diabetes in Pregnancy Screening.

Diabetes in Pregnancy Screening.
Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.

Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.
Stanford GEC Copyright © 2005 Mental Health Aspects of Diabetes in Elders from Diverse Ethnic Backgrounds Prepared by: Jill LeCount, RN, MS, CNS Based.

Stanford GEC Copyright © 2005 Mental Health Aspects of Diabetes in Elders from Diverse Ethnic Backgrounds Prepared by: Jill LeCount, RN, MS, CNS Based.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Demonstration Projects Core Elements Update July 28,

Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Demonstration Projects Core Elements Update July 28,
Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.

Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
Diabetes Prevention Group Screening and Eligibility Core Elements Update May 2005.

Diabetes Prevention Group Screening and Eligibility Core Elements Update May 2005.
A medical test to determine the ability of an individual to maintain HOMEOSTASIS of Blood Glucose The most commonly performed version of the Test (OGTT)

A medical test to determine the ability of an individual to maintain HOMEOSTASIS of Blood Glucose The most commonly performed version of the Test (OGTT)
Diagnosis of Type 2 Diabetes 1. Diagnostic Criteria for Prediabetes and Diabetes in Nonpregnant Adults 2 NormalHigh Risk for DiabetesDiabetes FPG

Diagnosis of Type 2 Diabetes 1. Diagnostic Criteria for Prediabetes and Diabetes in Nonpregnant Adults 2 NormalHigh Risk for DiabetesDiabetes FPG
Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.

Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.
Www.diabetes.org 1-800-DIABETES 1 The Value of Screening: HbA1c as a Diagnostic Tool David Kendall, MD Chief Scientific and Medical Officer American Diabetes.

DIABETES 1 The Value of Screening: HbA1c as a Diagnostic Tool David Kendall, MD Chief Scientific and Medical Officer American Diabetes.
O Identify whether all patients in the practice population diagnosed with IFG have had a repeat fasting blood glucose (FBG) within the past 12months o.

O Identify whether all patients in the practice population diagnosed with IFG have had a repeat fasting blood glucose (FBG) within the past 12months o.
Type 2 Diabetes- Treatment Toolbox by: Karen L. Staples, FNP, ACNP Where Do I Start?

Type 2 Diabetes- Treatment Toolbox by: Karen L. Staples, FNP, ACNP Where Do I Start?
Diagnosis of diabetes. Diabetic symptoms Diabetic symptoms + venous sample for : –Random venous ≥ 11.1 mmol/l (4.4-7.8) –Fasting glucose > 7(

Diagnosis of diabetes. Diabetic symptoms Diabetic symptoms + venous sample for : –Random venous ≥ 11.1 mmol/l ( ) –Fasting glucose > 7(
Mechanisms of Glucose Lowering of Dipeptidyl Peptidase-4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes A double-tracer study.

Mechanisms of Glucose Lowering of Dipeptidyl Peptidase-4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes A double-tracer study.
ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.

ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.
Screening for Type 1 & Type 2 Diabetes Key Messages In the absence of evidence for interventions to prevent or delay type 1 diabetes, screening for type.

Screening for Type 1 & Type 2 Diabetes Key Messages In the absence of evidence for interventions to prevent or delay type 1 diabetes, screening for type.
Diagnosis Glucose tolerance is classified into three broad categories: normal glucose homeostasis, diabetes mellitus, and impaired glucose homeostasis.

Diagnosis Glucose tolerance is classified into three broad categories: normal glucose homeostasis, diabetes mellitus, and impaired glucose homeostasis.
Identify the risk factors, diagnosis and prevalence of diabetes in the United States. Describe the function of the pancreas, the intestines and liver.

Identify the risk factors, diagnosis and prevalence of diabetes in the United States. Describe the function of the pancreas, the intestines and liver.

Similar presentations

Ads by Google